A new vitreal drug delivery system using an implantable biodegradable polymeric device.

作者: H Nishiwaki , Y Honda , Y Ikada , M Hashizoe , H Kimura

DOI:

关键词:

摘要: PURPOSE The authors evaluated the feasibility of using an implantable biodegradable polymeric device to deliver drugs into vitreous humor. METHODS Two types devices were prepared by compression-molding polymers poly(DL-lactic acid) two different molecular weights. weights used 5,600 (device-1) and 9,100 (device-2). Sodium fluorescein (NaF) served as a hydrophilic drug marker. release dye from was studied in vitro. intravitreal kinetics NaF rabbits vivo fluorophotometry. eyes electrophysiologically histologically determine if there toxic effects. RESULTS Device-1 device-2 released for more than 25 45 days, respectively, Detectable concentrations present up 17 days 28 Both well tolerated, with no noted CONCLUSIONS These results suggested that this may be potentially effective system vitreous.

参考文章(24)
G. A. Peyman, B. Khoobehi, Kwan-Rong Liu, Efficacy of liposome-bound amphotericin B for the treatment of experimental fungal endophthalmitis in rabbits. Investigative Ophthalmology & Visual Science. ,vol. 30, pp. 1527- 1534 ,(1989)
Suong-Hyu Hyon, Y. Honda, Y. Ikada, T. Moritera, R. Wada, Y. Ogura, Microspheres of biodegradable polymers as a drug-delivery system in the vitreous. Investigative Ophthalmology & Visual Science. ,vol. 32, pp. 1785- 1790 ,(1991)
Bahram Khoobehi, Gholam A Peyman, Omar M Aly, Manrique Ortiz Stradtmann, Clearance of sodium fluorescein incorporated into microspheres from the vitreous after intravitreal injection. Ophthalmic surgery. ,vol. 22, pp. 175- 180 ,(1991) , 10.3928/1542-8877-19910301-16
S H Hyon, Y Honda, Y Ikada, T Moritera, H Kimura, R Wada, Y Ogura, Injectable microspheres with controlled drug release for glaucoma filtering surgery Investigative Ophthalmology & Visual Science. ,vol. 33, pp. 3436- 3441 ,(1992)
R N Weinreb, M Blumenkranz, K K Assil, M Nehorayan, T Ward, M Hartzer, Liposome suppression of proliferative vitreoretinopathy. Rabbit model using antimetabolite encapsulated liposomes Investigative Ophthalmology & Visual Science. ,vol. 32, pp. 2891- 2897 ,(1991)
Suong-Hyu Hyon, N. Yoshimura, Y. Honda, Y. Ikada, T. Moritera, R. Wada, Y. Ogura, Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy. Investigative Ophthalmology & Visual Science. ,vol. 33, pp. 3125- 3130 ,(1992)
G A Peyman, T Lesar, P H Fishman, Intravitreal liposome-encapsulated gentamicin in a rabbit model. Prolonged therapeutic levels. Investigative Ophthalmology & Visual Science. ,vol. 27, pp. 1103- 1106 ,(1986)
Ben J. Glasgow, William C. Panek, David A. Lee, Calvin T. Eng, Karri W. Leong, The use of bioerodible polymers and 5-fluorouracil in glaucoma filtration surgery. Investigative Ophthalmology & Visual Science. ,vol. 29, pp. 1692- 1697 ,(1988)
M Barza, F Szoka, M Stuart, Effect of size and lipid composition on the pharmacokinetics of intravitreal liposomes. Investigative Ophthalmology & Visual Science. ,vol. 28, pp. 893- 900 ,(1987)
M Barza, J Baum, F Szoka, M Lahav, C Tremblay, Reduced toxicity of liposome-associated amphotericin B injected intravitreally in rabbits. Investigative Ophthalmology & Visual Science. ,vol. 26, pp. 711- 718 ,(1985)